Rockwell Medical (RMTI) Net Cash Flow Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -1,020.00% |
| 10 | Rockwell Medical | 28.48 Mn | 4.59 Mn | 2.90 Mn | 73.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.43% |
| Dec 31, 2025 | -188.42% |
| Sep 30, 2025 | 127.94% |
| Jun 30, 2025 | -78.29% |
| Mar 31, 2025 | -82.44% |
| Dec 31, 2024 | 171.87% |
| Sep 30, 2024 | 139.70% |
| Jun 30, 2024 | 370.11% |
| Mar 31, 2024 | -394.47% |
| Dec 31, 2023 | 142.49% |
| Sep 30, 2023 | 93.26% |
| Jun 30, 2023 | -109.27% |
| Mar 31, 2023 | 123.63% |
| Dec 31, 2022 | 71.53% |
| Sep 30, 2022 | -98.04% |
| Jun 30, 2022 | 732.94% |
| Mar 31, 2022 | 74.13% |
| Dec 31, 2021 | -27.44% |
| Sep 30, 2021 | -130.04% |
| Jun 30, 2021 | 69.19% |